Literature DB >> 12063545

Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.

Valentin Djonov1, Nicola Cresto, Daniel M Aebersold, Peter H Burri, Hans Jörg Altermatt, Miriana Hristic, Gilles Berclaz, Andrew Ziemiecki, Anne-Catherine Andres.   

Abstract

The metastatic potential of tumors is dependent on the ability of tumor cells to degrade extracellular matrix components by the expression of matrix metalloproteinases (MMPs) and to induce vascularisation of the tumor tissue. Thus, expression of MMPs and the number of blood vessel in tumor tissue may serve as prognostic markers of aggressive and metastasizing tumor growth. We have determined the vascularisation and the expression of MMP-2 by immuno-histochemical staining of 19 benign and 75 malignant breast tissue specimens with CD31- and MMP-2 specific antisera. The degree of vascularisation was expressed by intratumoral microvascular density (IMD), which takes into account all vessels present in a hot spot irrespective of their size. In addition, we have introduced a novel parameter, vascular grading (VG), which describes the percentage of small microvessels of <20 microm in diameter in the total number of blood vessels. IMD tended to indicate an elevated risk for metastasis formation and disease recurrence, while VG did not correlate with metastasis formation. Similarly, MMP-2 expression neither correlated with the clinical outcome of the disease nor with the classical histo-pathological parameters such as stage, grade, lymph node involvement and estrogen receptor status. Tumor cell-specific MMP-2 expression, however, showed a highly significant correlation with VG but not with IMD. These results indicate that MMP-2 expression is rather involved in the formation of small capillaries than in vessel maturation and tumor cell invasion. Thus, MMP-2 expression by tumor cells may serve as indicator of strong angiogenic induction potential of breast tumor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063545

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.

Authors:  Timothy G K Mant; Daniel Bradford; Dipti M Amin; Jaya Pisupati; Yoshikazu Kambayashi; Yoshitaka Yano; Kazushige Tanaka; Takuko Yamada-Sawada
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

3.  Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.

Authors:  Kalyan C Nannuru; Mitsuru Futakuchi; Michelle L Varney; Thomas M Vincent; Eric G Marcusson; Rakesh K Singh
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

Review 4.  (Dis)similarities between the Decidual and Tumor Microenvironment.

Authors:  Jelena Krstic; Alexander Deutsch; Julia Fuchs; Martin Gauster; Tina Gorsek Sparovec; Ursula Hiden; Julian Christopher Krappinger; Gerit Moser; Katrin Pansy; Marta Szmyra; Daniela Gold; Julia Feichtinger; Berthold Huppertz
Journal:  Biomedicines       Date:  2022-05-04

5.  Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.

Authors:  V Thumbigere-Math; B S Michalowicz; E P de Jong; T J Griffin; D L Basi; P J Hughes; M L Tsai; K K Swenson; L Rockwell; R Gopalakrishnan
Journal:  Oral Dis       Date:  2013-11-29       Impact factor: 3.511

6.  Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.

Authors:  Rose Du; Claudia Petritsch; Kan Lu; Patty Liu; Anna Haller; Ruth Ganss; Hanqiu Song; Scott Vandenberg; Gabriele Bergers
Journal:  Neuro Oncol       Date:  2008-03-21       Impact factor: 12.300

Review 7.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

8.  Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.

Authors:  Georgi Mishev; Elitsa Deliverska; Ruslan Hlushchuk; Nikolay Velinov; Daniel Aebersold; Felix Weinstein; Valentin Djonov
Journal:  Biotechnol Biotechnol Equip       Date:  2014-11-29       Impact factor: 1.632

9.  The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.

Authors:  Yiping Chen; Xiaochen Wang; Guodi Chen; Caixia Dong; Depu Zhang
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

10.  Radio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs.

Authors:  Moon-Taek Park; Eun-Taex Oh; Min-Jeong Song; Hyemi Lee; Heon Joo Park
Journal:  J Radiat Res       Date:  2012-06-14       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.